Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference CallBusiness Wire • 8 days ago
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for...
Share to Feed
Ben Klieve, an analyst from Lake Street, reiterated the Buy rating on Arcadia Biosciences (RKDA Research Report). The associated price target is...
Arcadia Biosciences ( NASDAQ:RKDA ) Full Year 2023 Results Key Financial Results Revenue: US$5.33m (down 28% from FY...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
RKDA stock results show that Arcadia Biosciences beat analyst estimates for earnings per share but missed on revenue for the fourth...
Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript...
Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript...
Arcadia Biosciences (RKDA) came out with a quarterly loss of $2.48 per share versus the Zacks Consensus Estimate of a loss of $2.68. This compares to loss of $6.31 per share a year ago. These figures...
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and...
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for...